Skip to content

UK clinical guideline for the prevention and treatment of osteoporosis

Research output: Contribution to journalArticle

Standard

UK clinical guideline for the prevention and treatment of osteoporosis. / Compston, J; Cooper, A; Cooper, Cyrus; Gittoes, N; Gregson, C; Harvey, N; Hope, S; Kanis, J A; McCloskey, E V; Poole, K E S; Reid, D M; Selby, P; Thompson, F; Thurston, A; Vine, N; National Osteoporosis Guideline Group (NOGG).

In: Archives of Osteoporosis, Vol. 12, No. 1, 12.2017, p. 43.

Research output: Contribution to journalArticle

Harvard

Compston, J, Cooper, A, Cooper, C, Gittoes, N, Gregson, C, Harvey, N, Hope, S, Kanis, JA, McCloskey, EV, Poole, KES, Reid, DM, Selby, P, Thompson, F, Thurston, A, Vine, N & National Osteoporosis Guideline Group (NOGG) 2017, 'UK clinical guideline for the prevention and treatment of osteoporosis' Archives of Osteoporosis, vol 12, no. 1, pp. 43. DOI: 10.1007/s11657-017-0324-5

APA

Compston, J., Cooper, A., Cooper, C., Gittoes, N., Gregson, C., Harvey, N., ... National Osteoporosis Guideline Group (NOGG) (2017). UK clinical guideline for the prevention and treatment of osteoporosis. Archives of Osteoporosis, 12(1), 43. DOI: 10.1007/s11657-017-0324-5

Vancouver

Compston J, Cooper A, Cooper C, Gittoes N, Gregson C, Harvey N et al. UK clinical guideline for the prevention and treatment of osteoporosis. Archives of Osteoporosis. 2017 Dec;12(1):43. Available from, DOI: 10.1007/s11657-017-0324-5

Author

Compston, J; Cooper, A; Cooper, Cyrus; Gittoes, N; Gregson, C; Harvey, N; Hope, S; Kanis, J A; McCloskey, E V; Poole, K E S; Reid, D M; Selby, P; Thompson, F; Thurston, A; Vine, N; National Osteoporosis Guideline Group (NOGG) / UK clinical guideline for the prevention and treatment of osteoporosis.

In: Archives of Osteoporosis, Vol. 12, No. 1, 12.2017, p. 43.

Research output: Contribution to journalArticle

Bibtex

@article{e1f728ecffeb4733ab6f42554702153f,
title = "UK clinical guideline for the prevention and treatment of osteoporosis",
abstract = "INTRODUCTION: In 2008, the UK National Osteoporosis Guideline Group (NOGG) produced a guideline on the prevention and treatment of osteoporosis, with an update in 2013. This paper presents a major update of the guideline, the scope of which is to review the assessment and management of osteoporosis and the prevention of fragility fractures in postmenopausal women and men age 50 years or over.METHODS: Where available, systematic reviews, meta-analyses and randomised controlled trials were used to provide the evidence base. Conclusions and recommendations were systematically graded according to the strength of the available evidence.RESULTS: Review of the evidence and recommendations are provided for the diagnosis of osteoporosis, fracture-risk assessment, lifestyle measures and pharmacological interventions, duration and monitoring of bisphosphonate therapy, glucocorticoid-induced osteoporosis, osteoporosis in men, postfracture care and intervention thresholds.CONCLUSION: The guideline, which has received accreditation from the National Institute of Health and Care Excellence (NICE), provides a comprehensive overview of the assessment and management of osteoporosis for all healthcare professionals who are involved in its management.",
keywords = "Journal Article",
author = "J Compston and A Cooper and Cyrus Cooper and N Gittoes and C Gregson and N Harvey and S Hope and Kanis, {J A} and McCloskey, {E V} and Poole, {K E S} and Reid, {D M} and P Selby and F Thompson and A Thurston and N Vine and {National Osteoporosis Guideline Group (NOGG)}",
year = "2017",
month = "4",
doi = "10.1007/s11657-017-0324-5",
volume = "12",
pages = "43",
journal = "Archives of Osteoporosis",
issn = "1862-3522",
publisher = "Springer Verlag",
number = "1",

}

RIS - suitable for import to EndNote

TY - JOUR

T1 - UK clinical guideline for the prevention and treatment of osteoporosis

AU - Compston,J

AU - Cooper,A

AU - Cooper,Cyrus

AU - Gittoes,N

AU - Gregson,C

AU - Harvey,N

AU - Hope,S

AU - Kanis,J A

AU - McCloskey,E V

AU - Poole,K E S

AU - Reid,D M

AU - Selby,P

AU - Thompson,F

AU - Thurston,A

AU - Vine,N

AU - National Osteoporosis Guideline Group (NOGG)

PY - 2017/4/19

Y1 - 2017/4/19

N2 - INTRODUCTION: In 2008, the UK National Osteoporosis Guideline Group (NOGG) produced a guideline on the prevention and treatment of osteoporosis, with an update in 2013. This paper presents a major update of the guideline, the scope of which is to review the assessment and management of osteoporosis and the prevention of fragility fractures in postmenopausal women and men age 50 years or over.METHODS: Where available, systematic reviews, meta-analyses and randomised controlled trials were used to provide the evidence base. Conclusions and recommendations were systematically graded according to the strength of the available evidence.RESULTS: Review of the evidence and recommendations are provided for the diagnosis of osteoporosis, fracture-risk assessment, lifestyle measures and pharmacological interventions, duration and monitoring of bisphosphonate therapy, glucocorticoid-induced osteoporosis, osteoporosis in men, postfracture care and intervention thresholds.CONCLUSION: The guideline, which has received accreditation from the National Institute of Health and Care Excellence (NICE), provides a comprehensive overview of the assessment and management of osteoporosis for all healthcare professionals who are involved in its management.

AB - INTRODUCTION: In 2008, the UK National Osteoporosis Guideline Group (NOGG) produced a guideline on the prevention and treatment of osteoporosis, with an update in 2013. This paper presents a major update of the guideline, the scope of which is to review the assessment and management of osteoporosis and the prevention of fragility fractures in postmenopausal women and men age 50 years or over.METHODS: Where available, systematic reviews, meta-analyses and randomised controlled trials were used to provide the evidence base. Conclusions and recommendations were systematically graded according to the strength of the available evidence.RESULTS: Review of the evidence and recommendations are provided for the diagnosis of osteoporosis, fracture-risk assessment, lifestyle measures and pharmacological interventions, duration and monitoring of bisphosphonate therapy, glucocorticoid-induced osteoporosis, osteoporosis in men, postfracture care and intervention thresholds.CONCLUSION: The guideline, which has received accreditation from the National Institute of Health and Care Excellence (NICE), provides a comprehensive overview of the assessment and management of osteoporosis for all healthcare professionals who are involved in its management.

KW - Journal Article

U2 - 10.1007/s11657-017-0324-5

DO - 10.1007/s11657-017-0324-5

M3 - Article

VL - 12

SP - 43

JO - Archives of Osteoporosis

T2 - Archives of Osteoporosis

JF - Archives of Osteoporosis

SN - 1862-3522

IS - 1

ER -